GlassScriptPhysician profile
Falguni Patel
NPI 1528268299
$18,563.34
in general payments reported to CMS, 2019-2025
9 companies · $783 in 2025
The $783 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,576 · 2020: $1,059 · 2021: $3,840 · 2022: $2,573 · 2023: $3,852 · 2024: $3,880 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,047 · Travel and Lodging: $1,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,047.01 |
| Travel and Lodging | $1,467.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $16,576.57 | 2019-2025 | Xeomin |
| Revance Therapeutics, INC. | $678.61 | 2024-2025 | Daxxify |
| Abbvie INC. | $446.07 | 2019-2025 | |
| Astrazeneca Uk Limited | $400.38 | 2024 | |
| Allergan, INC. | $351.84 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $53.98 | 2019-2020 | |
| Exact Sciences Corporation | $23.79 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $20.39 | 2025 | |
| Evofem Biosciences, INC. | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Falguni Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.